• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Catalog Number 10300
Device Problems Contamination (1120); Improper or Incorrect Procedure or Method (2017); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Information (3190)
Event Date 08/16/2016
Event Type  Injury  
Manufacturer Narrative
Investigation: the run data file (rdf) was analyzed for this event.No system-related root cause for the alleged bacterial contamination was identified.Review of the interface management images showed no abnormal behavior or foreign matter in the connector and signals in the rdf indicate the set was loaded and primed within the one-working shift recommendation provided in the spectra optia essentials guide.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported microbial contamination of a product collected on an optia set.At initial microbial testing, the product was negative, but after 5 days of incubation, the product had a (b)(6) test for coagulase reg.(b)(6).The unit was transfused to the patient.Prophylactic antifungal and antibiotic were given to the transfusion recipient.Patient information and outcome are not available at this time.Gender and weight in section a are for the donor.The spectra optia collect set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Investigation: a review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Per terumo bct's internal documentation, the devices terumo bct manufactures to collect, separate, and store blood products are terminally sterilized to a sterility assurance level (sal) of
 
Event Description
Due to eu personal data protection laws, the patient'sinformation and outcome are notavailable from the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information.Additional investigation: per terumo bct's medical review, the device did not cause or contribute to this incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
steve kern
10811 w. collins ave
lakewood, CO 80215
3032392246
MDR Report Key5997418
MDR Text Key56401673
Report Number1722028-2016-00538
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K153601
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 10/04/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/04/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/01/2018
Device Catalogue Number10300
Device Lot Number05Z3325
Other Device ID Number0502058310300
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/13/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/25/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Weight88
-
-